Cosmo pharmaceuticals

At Cosmo, we are committed to improve peoples lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Investors

Latest News

29 Apr 2025

Cosmo Pharmaceuticals Confirms Financial Guidance Following CHMP Opinion on Winlevi®

Read More
29 Apr 2025
AD HOC

Cosmo Receives Negative CHMP Opinion on Winlevi® (clascoterone Cream 1%) in Europe and Will Appeal the Decision

Read More
29 Apr 2025

Cosmo publishes agenda of AGM 2025

Read More

Upcoming Events

30 May 2025

Annual General Meeting 2025

Add to Outlook
03 Jun 2025-05 Jun 2025

Jefferies Healthcare Conference, New York

Add to Outlook
01 Jul 2025

Investor Day 2025

Add to Outlook

Latest presentation

19 Mar 2025
2024 Full Year Results (unaudited)

Therapeutic Focus

Cosmo’s therapeutic focus is on the treatment of gastrointestinal diseases (including IBD, colonic infections and colorectal cancer – CRC), increase the effectiveness of endoscopic examinations and to treat persistent skin conditions, like acne, and androgenetic alopecia, that have a long-term physical and emotional impact on lives and self-esteem.

Find out more

Our Mission

To improve people’s lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Find out more

Manufacturing

We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.

Find out more